Prescription ophthalmic immunomodulatory therapy to reduce severe ocular surface inflammation and protect the tear film.
Cyclosporine eye drops are an ophthalmic immunomodulator. Unlike steroids, which rapidly "switch off" inflammation but have limitations for long-term use, cyclosporine works more selectively and progressively. Its job is to reduce the local immune system's exaggerated reaction, allowing the tissues of the ocular surface (cornea and conjunctiva) to heal and the glands to resume producing high-quality tears.
Inhibits T-cells, reducing inflammatory molecules on the ocular surface.
Helps conjunctival goblet cells restore the natural mucin layer of the tear film.
Unlike steroids, it is designed for safe, chronic treatment over time.
Clinical scenarios requiring specialist evaluation for this advanced therapy.
Prescribing topical cyclosporine is a medical act. The ophthalmologist evaluates appropriateness, timing, and dosages based on the individual patient.
When immune modulation is not enough, the specialist may add or substitute biological and compounded therapies.
Blood-derived eye drops containing autologous growth factors to repair ulcers and severely damaged ocular surfaces.
Explore Autologous Serum →Compounded eye drops useful in neurotrophic keratitis to directly stimulate cellular regeneration.
Explore Insulin Drops →Off-label ophthalmic therapy to prevent corneal haze and scarring during the healing process or after trauma.
Explore Losartan Drops →How to correctly manage home ophthalmic therapy.
Topical therapies (cyclosporine, steroids, biological drops) act locally. In severe dry eye and systemic autoimmune diseases, efficacy increases when associated with an evaluation of lifestyle, the inflammatory axis, and the gut microbiome.
Learn More on Dry Eye →Explore our thematic portals for deeper insights into integrated visual protocols.